Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03677076 · ClinicalTrials.gov registry record
Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 14
- Enrollment target
NCT03677076: Completed study, sponsored by Medical University of South Carolina.
NCT03677076 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03677076 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This study is for patients with metastatic prostate cancer receiving radium-223 as their standard of care therapy. The researchers will collect blood and urine samples from patients before, during and after the radium-223 therapy. The researchers will compare these samples to observe how the treatment has affected different cancer markers.
Primary Outcome
The primary objective is to estimate average change in MAF in one or more clonal SNVs, comparing baseline to on-treatment, and baseline to post-treatment samples
Interventions
- OTHER Ancillary/Correlative
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2023-12-31 |
What the finished NCT03677076 record still lists
NCT03677076 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ancillary/Correlative is the first listed.
NCT03677076 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03677076 about?
NCT03677076 is a clinical study titled "Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer". This study is for patients with metastatic prostate cancer receiving radium-223 as their standard of care therapy. The researchers will collect blood and urine samples from patients before, during and after the radium-223 therapy. The researchers will compare these samples to observe how the treatme...
What is the current status of trial NCT03677076?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2019-03-04. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03677076?
The interventions under investigation include: Ancillary/Correlative (OTHER).
Who is sponsoring clinical trial NCT03677076?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy